PTC Therapeutics Inc.
PTCT | NASDAQ
$65.26
-$0.11 (-0.17%)
At close: Sep 21, 2026, 4:00 PM ET
$73.46
+$8.20 (+12.57%)
Pre-market:
Sep 22, 2026, 8:24 AM ET
Market Data
Market Cap $5.45B
Enterprise Value $3.91B
Beta 0.55
Average Volume 1.58M
Shares Outstanding (Diluted) 92.02M
Shares Change YoY 17.75%
Institutional Ownership N/A
Exchange NASDAQ
ISIN US69366J2006
Price Performance
Price Change 1M -6.4%
Price Change 3M -20.5%
Price Change 6M -2.2%
Price Change YTD -15.0%
Price Change 1Y 7.3%
Price Change 3Y 172.8%
Price Change 5Y 66.1%
1M CAGR (ann.) -11.0%
1Y CAGR (ann.) 3.8%
5Y CAGR (ann.) 9.4%
All-Time CAGR 10.9%
Valuation
PE Ratio -112.52
Forward PE 21.73
PEG Ratio 0.88
Forward PEG -1.17
PS Ratio 5.40
Forward PS 4.00
PB Ratio -32.94
P/FCF Ratio -72.98
P/Adj. FCF Ratio -34.19
P/OCF Ratio -176.38
EV/Sales 3.88
EV/EBIT -31.10
EV/EBITDA 62.59
EV/FCF -52.45
Earnings Yield -0.9%
FCF Yield -1.4%
Adj. FCF Yield -2.9%
Financial Health
Net Cash $1.53B
Total Debt $696.47M
Cash & Short-Term Investments $2.23B
Total Assets $3.25B
Current Ratio 3.39
Quick Ratio 3.28
Debt / Equity Ratio -4.21
Debt / EBITDA 11.14
Debt / FCF -9.33
OCF / Debt -0.04
Interest Coverage 0.63
Altman Z-Score 0.58
Piotroski F-Score 1
Margins & Profitability
Gross Profit Margin 82.1%
Operating Profit Margin 11.5%
EBITDA Margin 17.2%
Net Profit Margin -3.8%
FCF Margin -7.4%
Adj. FCF Margin -15.8%
SBC / Revenue 8.4%
SBC Impact (per share) -113.4%
Returns
Return on Assets -1.2%
Return on Equity 21.7%
Return on Invested Capital 2.6%
Return on Capital Employed 4.7%
Return on Tangible Assets -1.4%
Historical Growth (CAGR)
Revenue CAGR 3Y 7.2%
Revenue CAGR 5Y 16.4%
Revenue CAGR 10Y 33.3%
EPS CAGR 3Y 10743.8%
EPS CAGR 5Y 92.4%
EPS CAGR 10Y 10.4%
FCF CAGR 3Y 62.0%
FCF CAGR 5Y 212.4%
FCF CAGR 10Y 20.0%
Analyst Forecasts
Analyst Rating Buy
Analyst Count 26
EPS Growth Next 3Y 357.8%
Revenue Growth Next 3Y 20.2%
Earnings Date Nov 2, 2026
EPS Estimate (next Q) $0.29
EPS Growth Est (next Q) 45.9%
Revenue Est (next Q) $303.94M
Revenue Growth Est (next Q) 44.0%
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $105.13
Price Target Upside 61.1%
Cash Flow
Operating Cash Flow $-30.5M
Free Cash Flow $-74.63M
Adj. Free Cash Flow $-159.28M
FCF Per Share -$4.01
OCF Per Share -$0.37
OCF/S Ratio -3.0%
Income Statement
Revenue $1.01B
Gross Profit $476.39M
Operating Income $116.26M
EBITDA $62.53M
Net Income $-38.38M
EPS (Diluted) -$0.58
Revenue / Employee $1.02M
Profit / Employee $-38.73K
Employees 991
Add to Watchlist
Select watchlists to add or remove PTCT